★★★★☆
4.2 étoiles sur 5 de 618 commentaires client
2018-10-10
Strategies for Minimizing Risk Under the Foreign Corrupt Practices Act and Related Laws - de Mike Koehler (Author)
Details Strategies for Minimizing Risk Under the Foreign Corrupt Practices Act and Related Laws
Le tableau suivant sont affichées des faits spécifiques du Strategies for Minimizing Risk Under the Foreign Corrupt Practices Act and Related Laws
Le Titre Du Fichier | Strategies for Minimizing Risk Under the Foreign Corrupt Practices Act and Related Laws |
Date de Parution | 2018-10-10 |
Traducteur | Chaima Aoiffe |
Nombre de Pages | 331 Pages |
Taille du fichier | 25.46 MB |
Langue | Français et Anglais |
Éditeur | Sleepytown Press |
ISBN-10 | 3982907929-OYI |
Type de Fichier | EPub AMZ PDF MCW XMDF |
Écrivain | Mike Koehler |
Digital ISBN | 446-8388252206-KDS |
Nom de Fichier | Strategies-for-Minimizing-Risk-Under-the-Foreign-Corrupt-Practices-Act-and-Related-Laws.pdf |
Télécharger Strategies for Minimizing Risk Under the Foreign Corrupt Practices Act and Related Laws Livre PDF Gratuit
Noté 005 Achetez Strategies for Minimizing Risk Under the Foreign Corrupt Practices Act and Related Laws de Mike Koehler ISBN 9781788973571 sur des millions de livres livrés chez vous en 1 jour
Strategies for Minimizing Risk Under the Foreign Corrupt
Foreign Corrupt Practices Act FCPA UK Bribery Act Clean Company Act Brésil etc Certaines législations à portée extraterritoriale imposent déjà et ce de façon grandissante une pression sur les entreprises faisant affaires à l’étranger
payments to foreign officials or other third parties including the United States Foreign Corrupt Practices Act and the Canadian Corruption of Foreign Public Officials Act
A thoroughly pragmatic guide to the Foreign Corrupt Practices Act FCPA This is a critical FCPA training resource for executives managers sales marketing finance and accounting personnel as well as high level professionals
Pharmaceutical companies that conduct business in foreign jurisdictions are particularly at risk of FCPA violations because health care systems outside of the United States often are owned or operated by government agencies Therefore during the course of business activities interactions with individuals considered to be foreign officials can be more frequent than in other industries As a result there is heightened exposure to potential corruption risk
Foreign Corrupt Policies Act FCPA prohibits payments or offers of value to government officials parties or candidates in order to influence their acts or decisions as they relate to business opportunities